BioLife Solutions, Inc. Share Price & Technical Analysis
BLFS · $23.95 (-3.19%)
Healthcare / Medical Instruments & Supplies
$23.95
-3.19%
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, incl…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
14% return in May, 14% avg return in past 3 year May month.
4% return in 2026, 29% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | 11% | -19% | 9% | 14% | – | – | – | – | – | – | – | 4% |
| 25 | 4% | -9% | -12% | 7% | -9% | 0% | 0% | 21% | 3% | 10% | -5% | -7% | 2% |
| 24 | 7% | -1% | 27% | -4% | 21% | -1% | 12% | 7% | -2% | -6% | 17% | -5% | 70% |
| 23 | 25% | -1% | -6% | -19% | 31% | -5% | -10% | -33% | 3% | -27% | 25% | 32% | 16% |
| 22 | -21% | -21% | 1% | -44% | 8% | 0% | 41% | 24% | -2% | 4% | -12% | -14% | -36% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Strong
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.04B
P/E ratio
—
52W high
$29.62
52W low
$17.86
Volume
9,87,796
Beta
1.97
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is BioLife Solutions, Inc. share price today?
- BioLife Solutions, Inc. (BLFS) last traded around $23.95 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BLFS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BLFS. Download the app for real-time alerts.
- How can I analyze BioLife Solutions, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.